Leukemia, Myelogenous, Chronic, BCR-ABL Positive
"Leukemia, Myelogenous, Chronic, BCR-ABL Positive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
MeSH Number(s)
C04.557.337.539.250
C15.378.190.636.370
Concept/Terms
Leukemia, Myelogenous, Chronic, BCR-ABL Positive- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid, Philadelphia-Positive
- Leukemia, Granulocytic, Chronic
- Myeloid Leukemia, Chronic
- Chronic Myeloid Leukemia
- Chronic Myeloid Leukemias
- Leukemia, Chronic Myeloid
- Leukemias, Chronic Myeloid
- Myeloid Leukemias, Chronic
- Leukemia, Myeloid, Chronic
- Leukemia, Myelocytic, Chronic
- Myelocytic Leukemia, Chronic
- Chronic Myelocytic Leukemia
- Chronic Myelocytic Leukemias
- Leukemia, Chronic Myelocytic
- Leukemias, Chronic Myelocytic
- Myelocytic Leukemias, Chronic
- Leukemia, Myelogenous, Chronic
- Leukemia, Myelogenous, Ph1 Positive
- Leukemia, Myelogenous, Ph1-Positive
- Myelogenous Leukemia, Ph1-Positive
- Leukemia, Ph1-Positive Myelogenous
- Leukemias, Ph1-Positive Myelogenous
- Myelogenous Leukemia, Ph1 Positive
- Myelogenous Leukemias, Ph1-Positive
- Ph1-Positive Myelogenous Leukemia
- Ph1-Positive Myelogenous Leukemias
- Leukemia, Myeloid, Ph1 Positive
- Leukemia, Myeloid, Ph1-Positive
- Myeloid Leukemia, Ph1-Positive
- Leukemia, Ph1-Positive Myeloid
- Leukemias, Ph1-Positive Myeloid
- Myeloid Leukemia, Ph1 Positive
- Myeloid Leukemias, Ph1-Positive
- Ph1-Positive Myeloid Leukemia
- Ph1-Positive Myeloid Leukemias
- Myelogenous Leukemia, Chronic
- Chronic Myelogenous Leukemia
- Chronic Myelogenous Leukemias
- Leukemia, Chronic Myelogenous
- Leukemias, Chronic Myelogenous
- Myelogenous Leukemias, Chronic
- Leukemia, Myeloid, Philadelphia Positive
- Myeloid Leukemia, Philadelphia-Positive
- Leukemia, Philadelphia-Positive Myeloid
- Leukemias, Philadelphia-Positive Myeloid
- Myeloid Leukemia, Philadelphia Positive
- Myeloid Leukemias, Philadelphia-Positive
- Philadelphia-Positive Myeloid Leukemia
- Philadelphia-Positive Myeloid Leukemias
- Granulocytic Leukemia, Chronic
- Chronic Granulocytic Leukemia
- Chronic Granulocytic Leukemias
- Granulocytic Leukemias, Chronic
- Leukemia, Chronic Granulocytic
- Leukemias, Chronic Granulocytic
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myelogenous, Chronic, BCR-ABL Positive".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myelogenous, Chronic, BCR-ABL Positive".
This graph shows the total number of publications written about "Leukemia, Myelogenous, Chronic, BCR-ABL Positive" by people in Harvard Catalyst Profiles by year, and whether "Leukemia, Myelogenous, Chronic, BCR-ABL Positive" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 7 | 2 | 9 |
1994 | 9 | 6 | 15 |
1995 | 4 | 5 | 9 |
1996 | 4 | 4 | 8 |
1997 | 5 | 4 | 9 |
1998 | 12 | 2 | 14 |
1999 | 7 | 3 | 10 |
2000 | 7 | 2 | 9 |
2001 | 9 | 4 | 13 |
2002 | 10 | 2 | 12 |
2003 | 8 | 7 | 15 |
2004 | 10 | 4 | 14 |
2005 | 12 | 1 | 13 |
2006 | 10 | 5 | 15 |
2007 | 12 | 2 | 14 |
2008 | 11 | 5 | 16 |
2009 | 10 | 2 | 12 |
2010 | 15 | 5 | 20 |
2011 | 11 | 4 | 15 |
2012 | 18 | 0 | 18 |
2013 | 11 | 2 | 13 |
2014 | 17 | 1 | 18 |
2015 | 12 | 2 | 14 |
2016 | 13 | 4 | 17 |
2017 | 11 | 4 | 15 |
2018 | 14 | 1 | 15 |
2019 | 14 | 2 | 16 |
2020 | 13 | 1 | 14 |
2021 | 9 | 0 | 9 |
2022 | 14 | 0 | 14 |
Below are the most recent publications written about "Leukemia, Myelogenous, Chronic, BCR-ABL Positive" by people in Profiles.
-
ATYPICAL PROLIFERATIVE RETINOPATHY AS THE PRESENTING FEATURE OF CHRONIC MYELOID LEUKEMIA IN A PATIENT WITH DIABETES MELLITUS. Retin Cases Brief Rep. 2023 Jan 01; 17(1):61-64.
-
Cognition in patients treated with targeted therapy for chronic myeloid leukemia: a controlled comparison. Leuk Lymphoma. 2023 02; 64(2):415-423.
-
Secondary fusion proteins as a mechanism of BCR::ABL1 kinase-independent resistance in chronic myeloid leukaemia. Br J Haematol. 2023 02; 200(3):323-328.
-
Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells. Exp Hematol. 2022 11; 115:1-13.
-
Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia. Am J Hematol. 2022 11; 97(11):1419-1426.
-
Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia. Acta Haematol. 2022; 145(6):619-626.
-
A Ten-Year Experience of Treating Chronic Myeloid Leukemia in Rural Rwanda: Outcomes and Insights for a Changing Landscape. JCO Glob Oncol. 2022 07; 8:e2200131.
-
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia. Cell Death Dis. 2022 06 30; 13(6):576.
-
The Oncology Care Model and Adherence to Oral Cancer Drugs: A Difference-in-Differences Analysis. J Natl Cancer Inst. 2022 06 13; 114(6):871-877.
-
Synthetic Reprogramming of Kinases Expands Cellular Activities of Proteins. Angew Chem Int Ed Engl. 2022 07 18; 61(29):e202202770.